Volume 19 (2022)
Volume 18 (2021)
Volume 17 (2020)
Volume 16 (2019)
Volume 15 (2018)
Volume 14 (2017)
Volume 13 (2016)
Volume 12 (2015)
Volume 11 (2014)
Volume 10 (2013)
Volume 9 (2012)
Volume 8 (2011)
Volume 7 (2010)
Volume 6 (2009)
Volume 5 (2008)
Volume 4 (2007)
Volume 3 (2006)
Volume 2 (2005)
Volume 1 (2004)
1. Case Report of China/Tianjin's First Novel Coronavirus Variant Omicron

Haibai Sun; Hongjie Li; Shuping Huang; Lixia Shi; Zhiyan Xing; Jun Shen

Volume 19, Issue 1 , Winter 2022, , Pages 115-120


  COVID-19 is a new acute respiratory infectious disease caused by a novel Coronavirus (2019-COV-2) infection. On November 26, 2021, the World Health Organization announced a new 2019-COV-2 variant strain Omicron (B.1.1.529). Omicron's emergence added further uncertainty to the outbreak. Here we report ...  Read More

2. More Evidence of the Link of Interleukin-6 and Interleukin-10 with Critical COVID-19: A Report in Mexican Patients

German Reynaldo Jiménez-Gastélum; Arely Monserrant Espinoza-Ortega; Rosalío Ramos-Payán; Maribel Aguilar-Medina; Jorge López-Gutiérrez; Carlos Villegas-Mercado; Luis Antonio Ochoa-Ramirez; Horacio Rendón-Aguilar; Juan Fidel Osuna-Ramos; Juan José Ríos-Tostado; Jesús Salvador Velarde-Félix

Volume 18, Issue 4 , Autumn 2021, , Pages 331-337


  Background: According to the World Health Organization, Mexico presents one of the highest mortality rates due to coronavirus disease 2019 (COVID-19). The "cytokine storm" phenomenon has been proposed as a pathological hallmark of severe COVID-19. Objective: To determine the association of serum cytokine ...  Read More

3. The role and delicate balance of Host Immunity in Coronavirus Disease-19

Ashish Kumar Vyas; Vishwanath Varma; Garima Garg; Priyal Gupta; Nirupma Trehanpati

Volume 18, Issue 1 , Winter 2021, , Pages 1-12


  Severe Acute Respiratory Syndrome (SARS) associated with SARS-CoV-2, causes a severe form of the respiratory illness known as Coronavirus Disease-19 (COVID-19). COVID-19 has emerged as a worldwide pandemic with a high number of fatalities. Approximately 112,654,202 people have been infected so far with ...  Read More

4. Serological and Molecular Tests for COVID-19: a recent update

Amir Hossein Mansourabadi; Mona Sadeghalvad; Hamid-Reza Mohammadimotlagh; Aliakbar Amirzargar

Volume 18, Issue 1 , Winter 2021, , Pages 13-33


  The COVID-19 pandemic is probably the most devastating worldwide challenge in recent century. COVID-19 leads to a mild to severe respiratory disease and affects different organs and has become a global concern since December 2019. Meanwhile, molecular biology and diagnostic laboratories played an essential ...  Read More

5. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity

Saeid Taghiloo; Mohsen Soltanshahi; Masoud Aliyali; Siavash Abedi; Hossein Mehravaran; Abolghasem Ajami; Hossein Asgarian-Omran

Volume 18, Issue 1 , Winter 2021, , Pages 54-64


  Background: SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is recognized for the first time in Wuhan, China. The cytokine storm is a known factor causing major clinical symptoms leading to death in COVID-19 patients. Objective: To investigate and compare the serum levels of ...  Read More

6. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran

Sahar Mortezagholi; Davood Rostamzadeh; Maedeh Alinejad; Vahid Younesi; Payam Tabarsi; Mahdi Shabani

Volume 18, Issue 1 , Winter 2021, , Pages 82-92


  Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly transmits in general population, mainly between health-care workers (HCWs) who are in close contact with patients. Objective: To study the seropositivity of HCWs as a high-risk group compared to general population. Methods: ...  Read More